Everolimus plus exemestane improves bone health in post-menopausal women with ... RxPG NEWS By ECCO-the European CanCer Organisation, [RxPG] Vienna, Austria: Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, ... |
